Press Release: Mativ Announces Fourth Quarter and Full Year 2025 Results

Dow Jones
Feb 19
ALPHARETTA, Ga.--(BUSINESS WIRE)--February 18, 2026-- 

Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE: MATV) reported financial results for the three months and year ended December 31, 2025.

Mativ Fourth Quarter 2025 Highlights(1)

   --  Sales of $463.1 million increased 1.0% year over year, and 1.9% on an 
      organic basis 
 
   --  GAAP income was $100.8 million; GAAP EPS was $1.80 
 
   --  Adjusted income was $8.5 million; Adjusted EPS was $0.15 
 
   --  Adjusted EBITDA was $53.5 million, up 19% versus prior year 
 
   --  Adjusted EBITDA margin was 11.6%, up 180 basis points versus prior 
      year 
 
   --  Cash from operating activities was $19.3 million; Free cash flow was 
      $8.0 million 

Mativ Full Year 2025 Highlights

   --  Sales of $1,987.0 million increased 0.3% year over year, and 2.5% on an 
      organic basis 
 
   --  GAAP loss was $337.4 million; GAAP EPS was $(6.19) 
 
   --  Adjusted income was $42.6 million, and Adjusted EPS was $0.70 
 
   --  Adjusted EBITDA was $224.7 million, up 3% versus prior year 
 
   --  Adjusted EBITDA margin was 11.3%, up 30 basis points versus prior year 
 
 
   --  Cash from operating activities was $133.8 million, up 41% versus prior 
      year 
 
   --  Record full-year free cash flow was $93.8 million, up 139% versus prior 
      year 

Management Commentary

"Our strong fourth quarter capped a solid, transformational year for Mativ," said Shruti Singhal, Mativ President and CEO. "Q4 and full-year 2025 marked year-over-year improvements in sales, adjusted EBITDA and adjusted EBITDA margin. We also generated record free cash flow in 2025, more than double the amount compared to last year. The main drivers of our performance versus prior year for both the quarter and the fiscal year were disciplined commercial operational execution, prudent inventory management, favorable price versus input cost and steadfast SG&A expense management.

Throughout 2025, we made significant progress improving the performance of our company while simultaneously building a path for future profitable growth. We continue navigating an environment of anemic market demand and dynamic trade and macro-economic policies. However, we remain focused on delivering for our customers, improving our leverage and balance sheet by generating significant cash flow, and capturing volume and share gains that validate our go-to-market strategy. I am excited for our path ahead in 2026, as we continue our increased pace of execution to drive value for Mativ, our customers and our shareholders."

Mativ Fourth Quarter 2025 Financial Results

 
Filtration & 
Advanced 
Materials $(FAM)$              Three Months Ended December 31, 
                   --------------------------------------------------- 
(in millions; 
unaudited)              2025       2024    Change   2025      2024 
                       ------      -----  --------  ----      ---- 
Net Sales           $   177.2   $  167.8   $   9.4 
GAAP Operating 
 Profit & Margin 
 %                  $    16.2   $   10.3   $   5.9   9.1%      6.1% 
Adjusted EBITDA & 
 Margin %           $    33.2   $   26.3   $   6.9  18.7%     15.7% 
 

Filtration & Advanced Materials (FAM) segment sales, comprised primarily of filtration media and components, advanced films, coating and converting solutions, and extruded mesh products, were $177.2 million, up 5.6% versus the prior year period, reflecting higher volume/mix and favorable currency translation partially offset by lower selling prices.

GAAP Operating Profit in 2025 included $1.3 million of restructuring expenses, compared to $0.4 million in 2024. Adjusted EBITDA (see non-GAAP reconciliations) and margin increased 26.2% and 300 basis points, respectively, versus prior year as favorable net selling price versus input cost performance, higher volume/mix and lower SG&A expenses were partially offset by higher manufacturing costs.

 
Sustainable & 
Adhesive 
Solutions (SAS)           Three Months Ended December 31, 
                   --------------------------------------------- 
(in millions; 
unaudited)             2025    2024   Change  2025      2024 
                       -----   -----  ------  ----      ---- 
Net Sales           $  285.9  $290.8  $(4.9) 
GAAP Operating 
 Profit & Margin 
 %                  $   19.4  $ 15.3  $ 4.1    6.8%      5.3% 
Adjusted EBITDA & 
 Margin %           $   38.9  $ 35.8  $ 3.1   13.6%     12.3% 
 

Sustainable & Adhesive Solutions (SAS) segment sales, comprised primarily of tapes, labels, liners, specialty paper, packaging and healthcare solutions, of $285.9 million were down 0.3% on an organic basis, and down 1.7%, on a reported basis, versus the prior year period. Favorable currency translation and higher selling prices were more than offset by lower volume/mix.

GAAP Operating Profit in 2025 included $0.2 million in restructuring expenses, compared to $0.3 million of restructuring and other impairment expenses in 2024. Adjusted EBITDA (see non-GAAP reconciliations) and margin increased 8.7% and 130 basis points, respectively, compared to the prior year period, as lower manufacturing costs and favorable net selling price versus input cost performance were partially offset by lower volume/mix and higher distribution costs.

 
Unallocated           Three Months Ended December 31, 
                -------------------------------------------- 
(in millions; 
unaudited)       2025     2024    Change  2025      2024 
                 -----    -----   ------  ----      ---- 
GAAP Operating 
 Expense & % 
 of Sales       $(25.5)  $(23.0)  $(2.5)  (5.5)%    (5.0)% 
Adjusted 
 EBITDA & % of 
 Sales          $(18.6)  $(17.3)  $(1.3)  (4.0)%    (3.8)% 
 

GAAP operating expenses in 2025 included $2.3 million in organizational realignment costs.

Adjusted unallocated expenses (EBITDA) (see non-GAAP reconciliations) increased $1.3 million versus prior year primarily driven by the timing of employee-related expenses.

Interest expense was $17.0 million versus $19.7 million in the prior year period, mainly due to lower average balances on the floating portion of our outstanding debt in 2025.

Other income (expense), net was $(3.3) million and changed $12.2 million compared with the prior year primarily driven by foreign currency, and gains on asset sales in the prior year period.

Tax was a benefit for the three months ended December 31, 2025, primarily due to the impact from a decrease to our valuation allowance.

Non-GAAP Adjustments reflect items included in GAAP operating profit, income, and EPS, but excluded from adjusted results (see non-GAAP reconciliation tables for additional details). The most significant adjustment to the fourth quarter 2025 results were:

   --  $(1.98) per share due to the impact from a decrease to our valuation 
      allowance 
 
   --  $0.24 per share of purchase accounting expenses (purchase accounting 
      expenses reflect primarily ongoing non-cash intangible asset 
      amortizations associated with mergers and acquisitions) 
 
   --  $0.03 per share due to restructuring, restructuring related, and other 
      impairment expenses 

Cash Flow & Debt

Year-to-date 2025 cash provided by operating activities was $133.8 million. Capital spending and software costs totaled $40.0 million. Working capital was a $8.4 million source of cash due to the impact of a decrease in inventories and increase in accounts payable and other current liabilities partially offset by an increase in accounts receivable.

Total debt was $1,018.2 million as of December 31, 2025 and Cash and cash equivalents was $84.2 million resulting in net debt of $934.0 million. Total liquidity was approximately $515 million, consisting of $84 million of Cash and cash equivalents and $431 million of revolver availability. The Company's debt matures on a staggered basis between 2027 and 2029.

Dividend & Share Repurchases

On February 18, 2026, the Company announced its next quarterly cash dividend of $0.10 per share payable on March 27, 2026 to stockholders of record as of March 13, 2026.

During the fourth quarter, the Company did not repurchase shares.

Conference Call

Mativ will hold a conference call to review fourth quarter 2025 results with investors and analysts at 8:30 a.m. Eastern time on Thursday, February 19, 2026. The earnings conference call will be simultaneously broadcast over the Internet at http://ir.mativ.com. To listen to the call, please go to the Company's website at least 15 minutes prior to the call to register and to download and install any necessary audio software. For those unable to listen to the live broadcast, a replay will be available on the Company's website shortly after the call.

About Mativ

Mativ Holdings, Inc. is a global leader in specialty materials, solving our customers' most complex challenges by engineering bold, innovative solutions that connect, protect and purify our world. Headquartered in Alpharetta, Georgia, we manufacture on three continents and generate sales in over 100 countries through our family of business-to-business and consumer product brands. The company's two operating segments, Filtration & Advanced Materials and Sustainable & Adhesive Solutions, target premium applications across diversified and growing categories. Our broad portfolio of technologies combines polymers, fibers and resins to optimize the performance of our customers' products across multiple stages of the value chain. Our leading positions are a testament to our best-in-class global manufacturing, supply chain and materials science capabilities. We drive innovation and enhance performance, finding potential in the impossible.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") that are subject to the safe harbor created by the Act and other legal protections. Forward-looking statements include, without limitation, those regarding the Company's business plans, strategies and outlook, the adequacy of our sources of liquidity and capital, our expectations regarding dividends and share repurchases, the amount of capital spending and/or common stock repurchases, future cash flows, purchase accounting impacts, and other statements generally identified by words such as "believe," "expect," "intend," "guidance," "plan," "forecast," "potential," "anticipate," "confident," "project," "appear," "future," "should," "likely," "could," "may," "will," "typically" and similar words.

These forward-looking statements are prospective in nature and not based on historical facts, but rather on current expectations and on numerous assumptions regarding the business strategies and the environment in which the Company's business shall operate in the future and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that may cause actual results to differ materially from our expectations as of the date of this release. These risks include, among other things, the following factors:

   --  Risks associated with the implementation of our strategic growth 
      initiatives, including diversification, and the Company's understanding 
      of, and entry into, new industries and technologies; 
 
   --  Risks associated with acquisitions, dispositions, strategic 
      transactions and global asset realignment initiatives of Mativ; 
 
   --  Risks related to the impairment of goodwill; 
 
   --  Adverse changes in our end-market sectors impacting key customers; 
 
   --  Changes in the source and intensity of competition in our commercial 
      end-markets; 
 
   --  Adverse changes in sales or production volumes, pricing and/or 
      manufacturing costs; 
 
   --  Seasonal or cyclical market and industry fluctuations which may result 
      in reduced net sales and operating profits during certain periods; 
 
   --  Risks associated with our technological advantages in our intellectual 
      property and the likelihood that our current technological advantages are 
      unable to continue indefinitely; 
 
   --  Supply chain disruptions, including the failure of one or more material 
      suppliers, including energy, resin, fiber, and chemical suppliers, to 
      supply materials as needed to maintain our product plans and cost 
      structure; 
 
   --  Increases in operating costs due to inflation and continuing increases 
      in the inflation rate or otherwise, such as labor expense, compensation 
      and benefits costs; 
 
   --  Our ability to attract and retain key personnel, labor shortages, labor 
      strikes, stoppages or other disruptions; 
 
   --  Changes in general economic, financial and credit conditions in the 
      U.S., Europe, China and elsewhere, including the impact thereof on 
      currency exchange rates (including any weakening of the Euro) and on 
      interest rates; 
 
   --  A failure in our risk management and/or currency or interest rate swaps 
      and hedging programs, including the failures of any insurance company or 
      counterparty; 
 
   --  Changes in the manner in which we finance our debt and future capital 
      needs, including potential acquisitions; 
 
   --  Changes in tax rates, the adoption of new U.S. or international tax 
      legislation or exposure to additional tax liabilities; 
 
   --  Uncertainty as to the long-term value of the common stock of Mativ; 
 
   --  Changes in employment, wage and hour laws and regulations in the U.S. 
      and elsewhere, including unionization rules and regulations by the 
      National Labor Relations Board, equal pay initiatives, additional 
      anti-discrimination rules or tests and different interpretations of 
      exemptions from overtime laws; 
 
   --  The impact of tariffs, the imposition of any future additional tariffs 
      and other trade barriers, the effects of retaliatory trade measures, and 
      the impact of tariff uncertainty on macroeconomic conditions; 
 
   --  Existing and future governmental regulation and the enforcement thereof 
      that may materially restrict or adversely affect how we conduct business 
      and our financial results; 
 
   --  Weather conditions, including potential impacts, if any, from climate 
      change, known and unknown, and natural disasters or unusual weather 
      events; 
 
   --  International conflicts and disputes, such as the ongoing conflict 
      between Russia and Ukraine, the war between Israel and Hamas and the 
      broader regional conflict in the Middle East, which restrict our ability 
      to supply products into affected regions, due to the corresponding 
      effects on demand, the application of international sanctions, or 
      practical consequences on transportation, banking transactions, and other 
      commercial activities in troubled regions; 
 
   --  Compliance with the FCPA and other anti-corruption laws or trade 
      control laws, as well as other laws governing our operations; 
 
   --  Risks associated with pandemics and other public health emergencies; 
 
   --  The number, type, outcomes (by judgment or settlement) and costs of 
      legal, tax, regulatory or administrative proceedings, litigation and/or 
      amnesty programs; 
 
   --  Increased scrutiny from stakeholders related to environmental, social 
      and governance ("ESG") matters, as well as our ability to achieve our 
      broader ESG goals and objectives; 
 
   --  Costs and timing of implementation of any upgrades or changes to our 
      information technology systems; 
 
   --  Failure by us to comply with any privacy or data security laws or to 
      protect against theft of customer, employee and corporate sensitive 
      information; 
 
   --  Information technology system failures, data security breaches, network 
      disruptions, and cybersecurity events; and 
 
   --  Other factors described elsewhere in this document and from time to 
      time in documents that we file with the SEC. 

All forward-looking statements made in this document are qualified by these cautionary statements. Forward-looking statements herein are made only as of the date of this document, and Mativ undertakes no obligation, other than as may be required by law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise. For a more detailed discussion of these factors, also see the information under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Mativ's most recent annual report on Form 10-K for the year ended December 31, 2024 and any material updates to these factors contained in any of Mativ's future filings with the SEC. The discussion of these risks is specifically incorporated by reference into this release. The financial results reported in this release are unaudited.

Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such and should only be viewed as historical data. The financial results reported in this release are unaudited.

Non-GAAP Financial Measures

Certain financial measures and comments contained in this press release exclude restructuring and impairment expenses, certain purchase accounting adjustments related to prior acquisitions, organizational realignment and integration costs, divestiture costs, interest expense, stock compensation expense, the effect of income tax provisions and other tax impacts, capital spending, capitalized software costs, cloud-based software costs and depreciation and amortization. This press release also provides certain information regarding the Company's financial results excluding currency impacts. This information estimates the impact of changes in foreign currency rates on the translation of the Company's current financial results as compared to the applicable comparable period and is derived by translating the current local currency results into U.S. Dollars based upon the foreign currency exchange rates for the applicable comparable period. Financial measures which exclude or include these items have not been determined in accordance with accounting principles generally accepted in the United States (GAAP) and are therefore "non-GAAP" financial measures. Reconciliations of these non-GAAP financial measures to the most closely analogous measure determined in accordance with GAAP are included in the financial schedules attached to this release.

The Company believes that the presentation of non-GAAP financial measures in addition to the related GAAP measures provides investors with greater transparency on the information used by the Company's management in its financial and operational decision-making. Management also believes that the non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operational performance in the same way that management evaluates the Company's financial performance. Management believes that providing this information enables investors to better understand the Company's operating performance and financial condition. These non-GAAP financial measures are not calculated or presented in accordance with, and are not intended to be considered in isolation or as alternatives or substitutes for, or superior to, financial measures prepared and presented in accordance with GAAP, and should be read only in conjunction with the Company's financial measures prepared and presented in accordance with GAAP. The non-GAAP financial measures used in this release may be different from the measures used by other companies.

 
 
 
 MATIV HOLDINGS, INC. AND SUBSIDIARIES 
 CONSOLIDATED STATEMENTS OF INCOME (LOSS) 
 (in millions, except per share amounts) 
 (Unaudited) 
 
                            Three Months Ended December 31,           Year Ended December 31, 
                          ------------------------------------  ------------------------------------ 
                              2025          2024      % Change      2025          2024      % Change 
                           ----------    ----------   --------   ----------    ----------   -------- 
    Net sales             $     463.1   $     458.6     1.0%    $   1,987.0   $   1,981.1     0.3% 
    Cost of products 
     sold                       375.9         381.0    (1.3)%       1,624.1       1,617.0     0.4% 
                           ----------    ----------              ----------    ---------- 
Gross profit                     87.2          77.6    12.4%          362.9         364.1    (0.3)% 
 
   Selling and general 
    expense                      54.5          52.8     3.2%          228.7         233.8    (2.2)% 
   Research and 
    development expense           5.0           5.5    (9.1)%          23.6          23.0     2.6% 
   Intangible asset 
    amortization 
    expense                      15.9          16.0    (0.6)%          63.2          62.9     0.5% 
                           ----------    ----------              ----------    ---------- 
       Total 
        nonmanufacturing 
        expenses                 75.4          74.3     1.5%          315.5         319.7    (1.3)% 
 
    Goodwill impairment 
    expense                        --            --     N.M.          411.9            --     N.M. 
    Restructuring and 
     other impairment 
     expense                      1.7           0.7     N.M.           19.9          38.1   (47.8)% 
                           ----------    ----------              ----------    ---------- 
Operating profit (loss)          10.1           2.6     N.M.         (384.4)          6.3     N.M. 
    Interest expense             17.0          19.7   (13.7)%          71.1          74.7    (4.8)% 
    Loss on debt 
     extinguishment                --           7.3     N.M.             --           7.3     N.M. 
    Other income 
     (expense), net              (3.3)          8.9     N.M.           (7.5)         (3.2)    N.M. 
                           ----------    ----------              ----------    ---------- 
    Loss before income 
     taxes                      (10.2)        (15.5)  (34.2)%        (463.0)        (78.9)    N.M. 
    Income tax expense 
     (benefit), net            (111.0)        (17.0)    N.M.         (125.6)        (30.2)    N.M. 
                           ----------    ----------              ----------    ---------- 
Net income (loss)         $     100.8   $       1.5     N.M.    $    (337.4)  $     (48.7)    N.M. 
                           ==========    ==========              ==========    ========== 
 
Net income (loss) per 
share: 
    Basic                 $      1.84   $      0.03     N.M.    $     (6.19)  $     (0.90)    N.M. 
    Diluted               $      1.80   $      0.03     N.M.    $     (6.19)  $     (0.90)    N.M. 
 
Weighted average shares 
outstanding: 
    Basic                  54,681,100    54,335,800              54,607,100    54,313,300 
    Diluted                55,776,800    54,335,800              54,607,100    54,313,300 
 
N.M. - Not Meaningful 
 
 
 
 MATIV HOLDINGS, INC. AND SUBSIDIARIES 
 CONSOLIDATED BALANCE SHEETS 
 (in millions) 
 (Unaudited) 
 
                                           December 31,     December 31, 
                                                2025             2024 
                                          ---------------  --------------- 
ASSETS 
    Cash and cash equivalents              $        84.2    $         94.3 
    Restricted cash                                  5.6                -- 
    Accounts receivable, net                       180.9             162.4 
    Inventories, net                               329.1             355.1 
    Income taxes receivable                         17.7              20.6 
    Other current assets                            21.1              25.7 
                                              ----------       ----------- 
Total current assets                               638.6             658.1 
Property, plant and equipment, net                 609.1             620.3 
Finance lease right-of-use assets                   15.8              16.2 
Operating lease right-of-use assets                 48.4              46.4 
Deferred income tax assets                         104.0               8.1 
Goodwill                                            57.6             465.6 
Intangible assets, net                             514.2             553.4 
Other assets                                        63.9              79.8 
                                              ----------       ----------- 
Total assets                               $     2,051.6    $      2,447.9 
                                              ==========       =========== 
LIABILITIES AND STOCKHOLDERS' EQUITY 
    Current debt                           $         2.9    $          2.6 
    Finance lease liabilities                        1.8               1.6 
    Operating lease liabilities                      9.0               9.5 
    Accounts payable                               160.7             151.7 
    Income taxes payable                             1.5               8.4 
    Accrued expenses and other current 
     liabilities                                   109.4             100.7 
                                              ----------       ----------- 
Total current liabilities                          285.3             274.5 
Long-term debt                                   1,015.3           1,086.7 
Finance lease liabilities, noncurrent               16.1              16.3 
Operating lease liabilities, noncurrent             38.8              36.4 
Long-term income tax payable                          --                -- 
Pension and other postretirement 
 benefits                                           53.8              54.3 
Deferred income tax liabilities                     74.9             100.9 
Other liabilities                                   68.7              20.3 
                                              ----------       ----------- 
Total liabilities                                1,552.9           1,589.4 
Stockholders' equity: 
Preferred stock, $0.10 par value; 
10,000,000 shares authorized; none 
issued or outstanding                                 --                -- 
Common stock, $0.10 par value; 
 100,000,000 shares authorized; 
 54,681,114 and 54,335,830 shares issued 
 and outstanding at December 31, 2025 
 and December 31, 2024, respectively                 5.5               5.4 
    Additional paid-in-capital                     685.0             675.7 
    Retained earnings (accumulated 
     deficit)                                     (195.8)            164.3 
    Accumulated other comprehensive 
     income, net of tax                              4.0              13.1 
                                              ----------       ----------- 
Total stockholders' equity                         498.7             858.5 
                                              ----------       ----------- 
Total liabilities and stockholders' 
 equity                                    $     2,051.6    $      2,447.9 
                                              ==========       =========== 
 
 
MATIV HOLDINGS, INC. AND SUBSIDIARIES 
 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW 
 (in millions) 
 (Unaudited) 
                                               Year Ended December 31, 
                                           ------------------------------- 
                                                 2025            2024 
                                               ---------       -------- 
Operating 
Net loss                                    $     (337.4)     $   (48.7) 
  Adjustments to reconcile Net loss to 
  Net cash provided by operations: 
    Depreciation and amortization                  141.0          143.8 
    Amortization of deferred issuance 
     costs                                           8.2            7.8 
    Goodwill impairment                            411.9             -- 
    Other impairments                               11.8           16.2 
    Deferred income tax                           (130.2)         (34.3) 
    Pension and other postretirement 
     benefits                                       (2.9)          (5.9) 
    Stock-based compensation                        11.1           11.4 
    (Gain) loss on sale of assets                   (0.3)           5.5 
    (Gain) loss on foreign currency 
     transactions                                    6.6           (1.2) 
    Loss on debt extinguishment                       --            7.3 
    Other non-cash items                            10.0           (4.8) 
  Other operating                                   (4.4)          (2.4) 
  Net changes in operating working 
   capital                                           8.4            0.1 
                                               ---------       -------- 
          Net cash provided by operations          133.8           94.8 
Investing 
    Capital spending                               (40.0)         (55.0) 
    Proceeds from sale of assets                     2.9            5.8 
    Cash received from (paid on) 
     settlement of cross-currency swap 
     contracts                                       3.4           (1.7) 
    Other investing                                 (3.3)           6.2 
                                               ---------       -------- 
Net cash used in investing of: 
      Continuing operations                        (37.0)         (44.7) 
         Discontinued operations                      --          (12.0) 
                                               ---------       -------- 
            Net cash used in investing             (37.0)         (56.7) 
Financing 
    Cash dividends paid                            (22.3)         (21.6) 
    Proceeds from long-term debt                    82.0          531.0 
    Payments on long-term debt                    (161.9)        (554.7) 
    Payments for debt issuance costs                  --           (8.3) 
    Payments on financing lease 
     obligations                                    (3.1)          (1.5) 
    Shares withheld for employee taxes              (1.4)          (0.8) 
                                               ---------       -------- 
            Net cash used in financing            (106.7)         (55.9) 
Effect of exchange rate changes on Cash 
 and cash equivalents and Restricted 
 cash                                                5.4           (8.1) 
                                               ---------       -------- 
Decrease in cash and cash equivalents and 
 Restricted cash                                    (4.5)         (25.9) 
Cash and cash equivalents and Restricted 
 cash at beginning of period                        94.3          120.2 
                                               ---------       -------- 
Cash and cash equivalents and Restricted 
 cash at end of period                      $       89.8      $    94.3 
                                               =========       ======== 
 
 
MATIV HOLDINGS, INC. AND SUBSIDIARIES 
 BUSINESS SEGMENT REPORTING 
 (in millions) 
 (Unaudited) 
 
Segment Results 
                       Three Months Ended 
                          December 31,            Year Ended December 31, 
                   --------------------------  ------------------------------ 
                    2025    2024    % Change     2025      2024     % Change 
                    -----   -----  ----------   -------   -------  ---------- 
Net sales 
FAM                $177.2  $167.8    5.6%      $  767.5  $  766.5     0.1% 
SAS                 285.9   290.8   (1.7)%      1,219.5   1,214.6     0.4% 
                    -----   -----               -------   ------- 
    Total 
     Consolidated  $463.1  $458.6    1.0%      $1,987.0  $1,981.1     0.3% 
                    =====   =====               =======   ======= 
 
Cost of products 
sold 
    FAM            $137.4  $133.0    3.3%      $  604.2  $  592.3     2.0% 
    SAS             238.5   248.0   (3.8)%      1,019.9   1,024.7    (0.5)% 
                    -----   -----               -------   ------- 
Consolidated       $375.9  $381.0   (1.3)%     $1,624.1  $1,617.0     0.4% 
                    =====   =====               =======   ======= 
 
Total nonmanufacturing 
expenses 
    FAM            $ 22.1  $ 24.2   (8.7)%     $   94.4  $   98.6    (4.3)% 
    SAS              27.8    27.2    2.2%         112.3     115.5    (2.8)% 
                    -----   -----               -------   ------- 
Total segments       49.9    51.4   (2.9)%        206.7     214.1    (3.5)% 
    Unallocated      25.5    22.9   11.4%         108.8     105.6     3.0% 
                    -----   -----               -------   ------- 
Consolidated       $ 75.4  $ 74.3    1.5%      $  315.5  $  319.7    (1.3)% 
                    =====   =====               =======   ======= 
 
Restructuring and 
impairment 
    FAM            $  1.5  $  0.5        N.M.  $  428.7  $    5.6        N.M. 
    SAS               0.2     0.2     --%           1.7      29.1   (94.2)% 
                    -----   -----               -------   ------- 
Total segments        1.7     0.7        N.M.     430.4      34.7        N.M. 
    Unallocated        --      --        N.M.       1.4       3.4   (58.8)% 
                    -----   -----               -------   ------- 
Consolidated       $  1.7  $  0.7        N.M.  $  431.8  $   38.1        N.M. 
                    =====   =====               =======   ======= 
 
 
Operating profit (loss) 
                      Three Months Ended December 31,             Year Ended December 31, 
                   -------------------------------------  --------------------------------------- 
                                        Return on Net 
                                          Sales(1)                            Return on Net Sales 
                   -------  -------  -------------------  --------  --------  ------------------- 
                    2025     2024    2025      2024         2025      2024    2025       2024 
                    -----    -----   ----      ----  ---   ------    ------   -----      ---- 
FAM                $ 16.2   $ 10.3    9.1%      6.1%      $(359.8)  $  70.0   (46.9)%     9.1% 
SAS                  19.4     15.3    6.8%      5.3%         85.6      45.4     7.0%      3.7% 
Unallocated         (25.5)   (23.0)  (5.5)%    (5.0)%      (110.2)   (109.1)   (5.5)%    (5.5)% 
                    -----    -----                         ------    ------ 
    Total 
     Consolidated  $ 10.1   $  2.6    2.2%      0.6%      $(384.4)  $   6.3   (19.3)%     0.3% 
                    =====    =====                         ======    ====== 
    (1) Return on Net Sales (or "Margin Percentage") is calculated by dividing each performance 
    measure (Operating profit (loss), Adjusted Operating Profit, and Adjusted EBITDA) by Net 
    sales for the applicable period. Segment performance measures are divided by Net sales of 
    each segment. 
 
 
Non-GAAP Adjustments 
to Operating Profit 
(Loss) 
                           Three Months Ended         Year Ended 
                               December 31,           December 31, 
                        -------------------------  ----------------- 
                              2025         2024     2025    2024 
                            --------      -------   -----   ----- 
FAM - Amortization of 
 intangibles and other 
 purchase accounting 
 adjustments             $       8.8   $      8.5  $ 34.9  $ 34.5 
FAM - Restructuring, 
 restructuring 
 related, and 
 impairment expenses             1.3          0.4   431.0     5.6 
FAM - Organizational 
 realignment and 
 integration costs(2)             --          0.1      --     0.3 
SAS - Amortization of 
 intangibles and other 
 purchase accounting 
 adjustments                     7.1          7.0    28.4    28.3 
SAS - Restructuring, 
 restructuring 
 related, and 
 impairment expenses             0.2          0.3     1.7    28.5 
SAS - Organizational 
 realignment and 
 integration costs(2)             --           --      --    (0.1) 
Unallocated - 
 Restructuring, 
 restructuring 
 related, and 
 impairment expenses              --           --     1.4     3.4 
Unallocated - 
 Organizational 
 realignment and 
 integration costs(2)            2.3          1.9    13.7     9.9 
Unallocated - 
 Divestiture costs               0.6           --     2.0     3.6 
Unallocated - 
 Financing fees(1)               1.9          1.8     7.8     8.7 
Unallocated - 
 Amortization of 
 cloud-based software 
 costs                           0.4          0.2     1.4     0.5 
                            --------      -------   -----   ----- 
    Total Consolidated   $      22.6   $     20.2  $522.3  $123.2 
                            ========      =======   =====   ===== 
    (1) Financing fees incurred for the Receivables Sales Agreement. 
    (2) Costs associated with the CEO and CFO transitions, along 
    with the organizational realignment plan ("the Plan") announced 
    on January 24, 2024 totaled $2.3 million and $0.8 million for 
    the three months ended December 31, 2025 and 2024, respectively, 
    and $13.7 million and $4.5 million for the twelve months ended 
    December 31, 2025 and 2024, respectively. Costs associated with 
    the Plan included advisory fees and system-related initiatives. 
    Integration costs totaled $1.2 million and $5.6 million for the 
    three and twelve months ended December 31, 2024, respectively, 
    which included stock-based compensation, employee compensation, 
    and consulting fees. 
 
 
Adjusted Operating Profit 
                      Three Months Ended December 31,            Year Ended December 31, 
                   -------------------------------------  ------------------------------------- 
                                     Return on Net Sales                    Return on Net Sales 
                   -------  -------  -------------------  -------  -------  ------------------- 
                    2025     2024    2025      2024        2025     2024    2025      2024 
                    -----    -----   ----      ----  ---   -----    -----   ----      ----  --- 
FAM                $ 26.3   $ 19.3   14.8%     11.5%      $106.1   $110.4   13.8%     14.4% 
SAS                  26.7     22.6    9.3%      7.8%       115.7    102.1    9.5%      8.4% 
Unallocated         (20.3)   (19.1)  (4.4)%    (4.2)%      (83.9)   (83.0)  (4.2)%    (4.2)% 
                    -----    -----                         -----    ----- 
    Total 
     Consolidated  $ 32.7   $ 22.8    7.1%      5.0%      $137.9   $129.5    6.9%      6.5% 
                    =====    =====                         =====    ===== 
 
 
Non-GAAP Adjustments to 
Adjusted Operating 
Profit 
                             Three Months Ended         Year Ended 
                                 December 31,           December 31, 
                          -------------------------  ----------------- 
                                 2025         2024       2025    2024 
                          ---  --------  ---  -----      -----   ----- 
FAM - Depreciation          $       6.7    $    6.6   $   27.1  $ 26.8 
FAM - Stock-based 
 compensation(1)                    0.2         0.4        0.8     1.1 
SAS - Depreciation                 11.6        12.8       48.4    52.2 
SAS - Stock-based 
 compensation(1)                    0.6         0.4        1.7     1.0 
Unallocated - 
 Depreciation                       0.5         0.5        2.2     2.0 
Unallocated - 
 Stock-based 
 compensation(1)                    1.2         1.3        6.6     5.4 
                          ---  --------  ---  -----      -----   ----- 
    Total Consolidated      $      20.8    $   22.0   $   86.8  $ 88.5 
                          ===  ========  ===  =====      =====   ===== 
    (1) Stock-based compensation excludes stock-based compensation 
    included in restructuring and organizational realignment and 
    integration costs. 
 
 
Adjusted EBITDA 
                      Three Months Ended December 31,            Year Ended December 31, 
                   -------------------------------------  ------------------------------------- 
                                     Return on Net Sales                    Return on Net Sales 
                   -------  -------  -------------------  -------  -------  ------------------- 
                    2025     2024    2025      2024        2025     2024    2025      2024 
                    -----    -----   ----      ----  ---   -----    -----   ----      ----  --- 
FAM                $ 33.2   $ 26.3   18.7%     15.7%      $134.0   $138.3   17.5%     18.0% 
SAS                  38.9     35.8   13.6%     12.3%       165.8    155.3   13.6%     12.8% 
Unallocated         (18.6)   (17.3)  (4.0)%    (3.8)%      (75.1)   (75.6)  (3.8)%    (3.8)% 
                    -----    -----                         -----    ----- 
    Total 
     Consolidated  $ 53.5   $ 44.8   11.6%      9.8%      $224.7   $218.0   11.3%     11.0% 
                    =====    =====                         =====    ===== 
 
 
Non-GAAP Reconciliation of Organic Net Sales Growth 
 
                            FAM            SAS       Consolidated Mativ 
                      ---------------  ------------  ------------------- 
                               Three Months Ended December 31, 
                      -------------------------------------------------- 
 
Mativ 2024 Net Sales   $   167.8       $  290.8       $       458.6 
Divestiture/closure 
 adjustments                  --           (4.1)               (4.1) 
                          ------  ---   -------          ---------- 
    Mativ 2024 
     comparable Net 
     Sales             $   167.8       $  286.7       $       454.5 
 
Mativ 2025 Net Sales   $   177.2       $  285.9       $       463.1 
Divestiture/closure 
adjustments                   --             --                  -- 
                          ------  ---   -------          ----------  --- 
    Mativ 2025 
     comparable Net 
     Sales             $   177.2       $  285.9       $       463.1 
    Organic growth           5.6%          (0.3)%               1.9% 
 
Currency effects on 
 2025                  $     4.1       $    5.1       $         9.2 
                          ------  ---   -------          ----------  --- 
    Mativ 2025 
     comparable Net 
     Sales with 
     Currency 
     Adjustment        $   173.1       $  280.8       $       453.9 
    Organic constant 
     currency 
     growth                  3.2%          (2.1)%              (0.1)% 
 
                            FAM            SAS       Consolidated Mativ 
                      ---------------  ------------  ------------------- 
                                   Year Ended December 31, 
                      -------------------------------------------------- 
 
Mativ 2024 Net Sales   $   766.5       $1,214.6       $     1,981.1 
Divestiture/closure 
 adjustments                  --          (42.3)              (42.3) 
                          ------  ---   -------          ---------- 
    Mativ 2024 
     comparable Net 
     Sales             $   766.5       $1,172.3       $     1,938.8 
 
Mativ 2025 Net Sales   $   767.5       $1,219.5       $     1,987.0 
Divestiture/closure 
adjustments                   --             --                  -- 
                          ------  ---   -------          ----------  --- 
    Mativ 2025 
     comparable Net 
     Sales             $   767.5       $1,219.5       $     1,987.0 
    Organic growth           0.1%           4.0%                2.5% 
 
Currency effects on 
 2025                  $     8.6       $   11.1       $        19.7 
                          ------  ---   -------          ----------  --- 
    Mativ 2025 
     comparable Net 
     Sales with 
     Currency 
     Adjustment        $   758.9       $1,208.4       $     1,967.3 
    Organic constant 
     currency 
     growth                 (1.0)%          3.1%                1.5% 
 
 
 
MATIV HOLDINGS, INC. AND SUBSIDIARIES 
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES AND 
SUPPLEMENTAL DATA 
(in millions, except per share amounts) 
                  Three Months Ended         Year Ended 
                      December 31,           December 31, 
                 ----------------------  ------------------- 
                      2025       2024      2025     2024 
                     -------    ------    ------    ----- 
Operating 
 profit (loss)    $     10.1   $   2.6   $(384.4)  $  6.3 
Plus: 
 Restructuring, 
 restructuring 
 related, and 
 impairment 
 expenses                1.5       0.7      22.2     37.5 
Plus: Goodwill 
impairment                --        --     411.9       -- 
Plus: Purchase 
 accounting 
 adjustments            15.9      15.5      63.3     62.8 
Plus: 
 Organizational 
 realignment 
 and 
 integration 
 costs                   2.3       2.0      13.7     10.1 
Plus: 
 Divestiture 
 costs                   0.6        --       2.0      3.6 
Plus: Financing 
 fees                    1.9       1.8       7.8      8.7 
Plus: 
 Amortization 
 of cloud-based 
 software 
 costs                   0.4       0.2       1.4      0.5 
                     -------    ------    ------    ----- 
Adjusted 
 operating 
 profit           $     32.7   $  22.8   $ 137.9   $129.5 
                     =======    ======    ======    ===== 
 
Net income 
 (loss)           $    100.8   $   1.5   $(337.4)  $(48.7) 
Plus: 
 Restructuring, 
 restructuring 
 related, and 
 impairment 
 expenses                1.5       0.6      20.9     32.4 
Plus: Goodwill 
 impairment             (7.4)       --     339.8       -- 
Plus: Gain/loss 
 on sale of 
 assets                   --      (3.4)       --      2.4 
Plus: Purchase 
 accounting 
 adjustments            13.2      11.9      56.9     48.4 
Plus: 
 Litigation/tax 
 settlement               --       1.0        --      1.0 
Plus: 
 Organizational 
 realignment 
 and 
 integration 
 costs                   2.3       1.6      13.7      7.7 
Plus: 
 Divestiture 
 costs                   0.6      (0.1)      2.0      2.7 
Plus: Other               --       3.7        --      4.8 
Plus: Change of 
 valuation 
 allowance on 
 tax 
 attributes           (110.4)    (14.9)    (61.0)   (14.9) 
Plus: Tax 
 legislative 
 changes, net 
 of other 
 discrete 
 items                   7.9       1.1       7.7     (1.7) 
                     -------    ------    ------    ----- 
Adjusted income 
 (loss)           $      8.5   $   3.0   $  42.6   $ 34.1 
                     =======    ======    ======    ===== 
 
Earnings (loss) 
 per share - 
 diluted          $     1.80   $  0.03   $ (6.19)  $(0.90) 
Plus: 
 Restructuring, 
 restructuring 
 related, and 
 impairment 
 expenses               0.03      0.01      0.38     0.59 
Plus: Goodwill 
 impairment            (0.13)       --      6.16       -- 
Plus: Gain/loss 
 on sale of 
 assets                   --     (0.06)       --     0.04 
Plus: Purchase 
 accounting 
 adjustments            0.24      0.21      1.03     0.89 
Plus: 
 Litigation/tax 
 settlement               --      0.02        --     0.02 
Plus: 
 Organizational 
 realignment 
 and 
 integration 
 costs                  0.04      0.03      0.25     0.14 
Plus: 
 Divestiture 
 costs                  0.01        --      0.04     0.05 
Plus: Other               --      0.07        --     0.09 
Plus: Change of 
 valuation 
 allowance on 
 tax 
 attributes            (1.98)    (0.27)    (1.11)   (0.27) 
Plus: Tax 
 legislative 
 changes, net 
 of other 
 discrete 
 items                  0.14      0.01      0.14    (0.03) 
                     -------    ------    ------    ----- 
Adjusted 
 Earnings 
 (loss) per 
 share - 
 diluted          $     0.15   $  0.05   $  0.70   $ 0.62 
                     =======    ======    ======    ===== 
 
 
MATIV HOLDINGS, INC. AND SUBSIDIARIES 
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES 
AND SUPPLEMENTAL DATA 
(in millions, except per share amounts) 
                   Three Months 
                  Ended December         Year Ended 
                        31,              December 31, 
                 -----------------  ---------------------- 
                   2025     2024      2025       2024 
                  ------    -----    -------    ------- 
Net income 
 (loss)          $ 100.8   $  1.5   $ (337.4)  $  (48.7) 
Plus: Interest 
 expense            17.0     19.7       71.1       74.7 
Plus: Financing 
 fees                1.9      1.8        7.8        8.7 
Plus: Provision 
 for income 
 taxes            (111.0)   (17.0)    (125.6)     (30.2) 
Plus: 
 Depreciation & 
 amortization       34.7     35.4      141.0      143.8 
Plus: 
 Amortization 
 of cloud-based 
 software 
 costs               0.4      0.2        1.4        0.5 
Plus: Stock 
 compensation 
 expense             2.0      2.1        9.1        7.5 
Plus: 
 Restructuring, 
 restructuring 
 related, and 
 impairment 
 expenses            1.5      0.7       22.2       37.5 
Plus: Goodwill 
impairment            --       --      411.9         -- 
Plus: 
 Organizational 
 realignment 
 and 
 integration 
 costs               2.3      2.0       13.7       10.1 
Plus: 
 Divestiture 
 costs               0.6       --        2.0        3.6 
Plus: Loss on 
 debt 
 extinguishment       --      7.3         --        7.3 
Plus: Other 
 (income) 
 expense, net        3.3     (8.9)       7.5        3.2 
                  ------    -----    -------    ------- 
Adjusted EBITDA  $  53.5   $ 44.8   $  224.7   $  218.0 
                  ======    =====    =======    ======= 
 
Cash provided 
 by operating 
 activities      $  19.3   $ 24.1   $  133.8   $   94.8 
Less: Capital 
 spending          (11.3)   (22.1)     (40.0)     (55.0) 
Less: 
 Capitalized 
 software 
 costs                --     (0.1)        --       (0.6) 
                  ------    -----    -------    ------- 
Free cash flow   $   8.0   $  1.9   $   93.8   $   39.2 
                  ======    =====    =======    ======= 
 
                                    December    December 
                                    31, 2025    31, 2024 
                                    ---------  ----------- 
Total debt                          $1,018.2   $1,089.3 
Less: Cash                              84.2       94.3 
                                     -------    ------- 
Net debt                            $  934.0   $  995.0 
                                     =======    ======= 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260218412211/en/

 
    CONTACT:    Chris Kuepper, IRC 

Director, Investor Relations

+1-770-569-4229

Website: http://www.mativ.com

 
 

(END) Dow Jones Newswires

February 18, 2026 16:11 ET (21:11 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10